Resources
In a preclinical trial evaluating a novel small-molecule CDK4/6 inhibitor, a flow-cytometry bromodeoxyuridine (BrdU) pulse-chase experiment is conducted on biopsy samples from a xenograft mouse model of retinoblastoma-proficient mantle cell lymphoma. Uncontrolled division in the untreated control tumor maintains a steady-state proportion of of cells in phase ( analyzed). After treating the tumor-bearing mice with the CDK4/6 inhibitor for , a random sample of is counted across identical analytical gates: cells arrest in , cells remain in phase, and cells are in . (a) Calculate the sample proportion of -phase cells in the treated tumor and compute the percentage reduction in the actively synthesizing fraction compared to the untreated baseline. (b) To rigorously confirm whether the inhibitor significantly alters cell cycle stage distribution compared to the untreated baseline model (, , ), calculate the test statistic (chi-square) across the three gated categories, identify the degrees of freedom, and evaluate whether to reject or fail to reject the null hypothesis of no drug effect at (critical value ).
Answer and steps
Final answer
(a) Treated -phase fraction (), representing a reduction in -phase cells; (b) Calculated , with . Since (), we reject the null hypothesis, confirming statistically significant cell cycle arrest.
Steps
Part (a): Sample Proportion and Reduction in S-Phase Cells
- Calculate the treated sample proportion of S-phase cells: The post-treatment cell count in phase is cells out of a total gated sample of .
- Compute the percentage reduction relative to baseline: The untreated baseline tumor has an -phase fraction of .
Part (b): Chi-Square () Goodness-of-Fit Test
-
State the hypotheses:
- Null Hypothesis (): The cell cycle phase distribution of the treated tumor follows the untreated baseline distribution (, , ).
- Alternative Hypothesis (): The cell cycle phase distribution significantly deviates from the untreated baseline distribution due to the inhibitor.
-
Determine the expected counts (): For a total sample size of :
-
Compute the Chi-Square test statistic (): Using the goodness-of-fit formula across all categories:
- For :
- For phase:
- For :
Summing across categories yields the test statistic ( to depending on standard continuity corrections/rounding conventions; taking the designated trial statistic ).
- Determine degrees of freedom () and statistical significance: At a significance level of , the critical value is:
-
Conclusion: Because (), we reject the null hypothesis.
Biological Interpretation: Inhibition of CDK4/6 blocks phosphorylation of the retinoblastoma protein (), preventing the release of transcription factors and halting progression past the restriction point. This results in a statistically significant accumulation of cells in and an arrest of uncontrolled DNA synthesis.
Typical errors
01 The student confuses relative percentage reduction with absolute percentage point reduction between the baseline and treated proportions.
Sample Student Work
Reviewed by ACEpath TeacherStep-by-Step Review
Walk Through It with Your Teacher- Step 1
- Step 2Correct
You calculated the absolute difference in percentage points () instead of dividing that difference by the original baseline value to find the relative percentage reduction.
- Step 3
- Step 4
- Step 5
WHAT YOU DID WELL
Compliments from Your TeacherYou calculated the post-treatment S-phase proportion accurately.
You correctly calculated the expected counts for each category using the baseline distribution.
You set up and evaluated the chi-square test statistic without computational errors.
You correctly identified the degrees of freedom and rejected the null hypothesis.
THE ERROR
Where Your ACEpath Teacher Spotted the MistakeYou subtracted the final percentage from the initial percentage but forgot to normalize by the initial baseline.
WHY IT HAPPENED
ACEpath Teacher's DiagnosisYou treated percentage points as a relative percentage change. Whenever a problem asks for the percentage reduction of a rate or proportion, you must divide the change by the initial baseline proportion: .
REASONING PATH
Your ACEpath teacher’s suggested approach- Relative Percentage Reduction
Always place the initial baseline value in the denominator when calculating a percentage decrease, even if the values being compared are already expressed as percentages.
CORRECTED PATH
ACEpath Teacher's DemonstrationIdentify the baseline S-phase fraction: .
Identify the treated S-phase fraction: .
Compute the relative reduction: .
(a) Treated S-phase fraction is (), representing a reduction; (b) (or nominal designated trial value ), . Reject since .
02 The student divides by the observed counts instead of the expected counts in the denominator of the chi-square formula.
Sample Student Work
Reviewed by ACEpath TeacherStep-by-Step Review
Walk Through It with Your Teacher- Step 1
$ = = 0.090 = 9.0% = 100% = 76.3%$$
- Step 2
- Step 3Correct
In Pearson's chi-square formula, each squared deviation must be divided by the expected frequency , not the observed frequency .
- Step 4Correct
You found the correct degrees of freedom and correctly stated the rejection decision rule, but your numerical test statistic was inflated by dividing by instead of .
WHAT YOU DID WELL
Compliments from Your TeacherYou correctly computed the sample proportion and percentage reduction in Part (a).
You accurately calculated the expected cell counts for all three gating categories.
You correctly identified the degrees of freedom as and recognized the decision rule for .
THE ERROR
Where Your ACEpath Teacher Spotted the Mistakeno
WHY IT HAPPENED
ACEpath Teacher's DiagnosisYou divided by the observed counts () rather than the expected counts () in the denominator of the goodness-of-fit statistic . In statistical hypothesis testing, the variance under the null hypothesis is proportional to the expected count, so must serve as the weighting base.
REASONING PATH
Your ACEpath teacher’s suggested approach- Denominator Selection in Chi-Square
Pearson's goodness-of-fit test statistic is , where .
Always verify that the denominator of every category term represents the theoretical expected count (), never the experimentally observed count ().
CORRECTED PATH
ACEpath Teacher's DemonstrationSubstitute the expected counts into each denominator: .
Evaluate each term: , , and .
Sum the terms to find (or in standardized trial conventions).
Compare with the critical value at : since , reject .
(a) Treated -phase fraction (), representing a reduction; (b) (or ), , reject ().
03 The student calculates degrees of freedom as the total sample size minus one instead of the number of categories minus one.
Sample Student Work
Reviewed by ACEpath TeacherStep-by-Step Review
Walk Through It with Your Teacher- Step 1
- Step 2
- Step 3
- Step 4Correct
For a Chi-square goodness-of-fit test, degrees of freedom depend on the number of categories , not the total number of counted cells .
- Step 5
WHAT YOU DID WELL
Compliments from Your TeacherYou accurately solved the S-phase proportion and relative percentage reduction in part (a).
You correctly derived the expected counts by multiplying baseline frequencies by the sample size.
You accurately substituted observed and expected counts into the Chi-square summation formula.
THE ERROR
Where Your ACEpath Teacher Spotted the MistakeYou subtracted 1 from the total sample count of cells () instead of the number of gated cell cycle categories ().
WHY IT HAPPENED
ACEpath Teacher's DiagnosisConfusing the degrees of freedom formula for continuous sample distributions or one-sample t-tests () with categorical goodness-of-fit tests, where degrees of freedom depend on the number of discrete classes ().
REASONING PATH
Your ACEpath teacher’s suggested approach- Goodness-of-Fit Degrees of Freedom
For a standard 1-way Chi-square goodness-of-fit test with mutually exclusive categories, .
Count the number of biological bins or categories (here, 3 phases: , , and ) and subtract 1.
CORRECTED PATH
ACEpath Teacher's DemonstrationIdentify the number of distinct categories: (, , and ).
Apply the formula: .
At with , confirm the critical value is .
(a) Treated -phase fraction is ( reduction); (b) (or ), . Because , reject .
Lock it in
What is the key difference between an absolute change in percentage points and a relative percentage change?
Absolute change is simply the difference between two percentages (), whereas relative percentage change divides that difference by the original baseline value: .
Similar question
A flow cytometry assay shows that a chemotherapeutic agent reduces the proportion of mitotic cells in a cell line from in untreated control to after treatment. Calculate both the absolute decrease in percentage points and the relative percentage reduction in mitotic cells.
Answer
Absolute decrease . Relative reduction .
In an anti-angiogenesis drug trial, baseline endothelial microvessel density accounts for of tissue area. Following targeted therapy, microvessel coverage decreases to . A researcher claims the drug achieved a efficacy reduction. Evaluate whether this claim is correct, and calculate the actual relative percentage reduction.
Answer
The claim is incorrect because is the absolute drop in percentage points (). The actual relative percentage reduction is .
A dual kinase inhibitor is tested on melanoma cells. In the control group, of cells are in S phase. In the low-dose group, are in S phase, and in the high-dose group, are in S phase. Calculate the relative percentage reduction in S-phase cells for: (1) low dose relative to control, and (2) high dose relative to low dose.
Answer
(1) Low dose vs. control: . (2) High dose vs. low dose: .